|
|
Cell-of-Origin (COO) Classification, BCL2 and MYC Expression Associated Outcome in Younger Patients Treated By RCHOP Front-Line Therapy Versus Intensive Regimen Followed By Autologous Transplant for De Novo Advanced Diffuse Large B Cell Lymphoma (DLBCL) : Results of the French Prospective Multicenter Randomized Trial Goelams-075
Gaëlle Laboure
,
Marie-Cecile Parrens
,
Anjarasoa Tsaranazy
,
Magali Bordier
,
Steven Le Gouill
et al.
55th Annual Meeting and Exposition of the American-Society-of-Hematology, Dec 2013, La Nouvelle Orléans, United States. 126 (23), pp.3920, 2015
Conference poster
hal-01290432v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Biological differences between two commercial anti-CD19 CAR T cells products and impact on outcomes in lymphoma patients.
Benoit Tessoulin
,
Audrey Grain
,
Jocelyn Ollier
,
Thomas Gastinne
,
Viviane Dubruille
et al.
The 64th American Society of Hematology Annual Meeting and Exposition ASH 2022, Dec 2022, New Orleans, Louisiana, United States
Conference poster
inserm-03956740v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prise en compte de l'adaptation des propriétés mécaniques de la cellule pendant l'endocytose de nanoparticules
Sarah Iaquinta
,
Shahram Khazaie
,
Sylvain Fréour
,
Frédéric Jacquemin
,
Christophe Blanquart
et al.
15e journées du Cancéropôle Nantes Angers, Jul 2021, Angers, France
Conference poster
hal-03993849v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|